A

Avectas

33 employees

Avectas is a cell engineering technology company that enables drug developers to manufacture potent engineered cell therapies.

Basic info

Industry

biotechnology research

Sectors

CRISPR
Biotechnology
Health Care
Transfection
Gene Therapy
CAR-T
Cell Engineering
Medical
Cell Therapy
Gene Editing

Date founded

2011

Funding rounds raised

Total raised

$3.6M

from 1 investors over 1 rounds

A

Avectas raised $3.6M on May 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ